Icon Plc Company Profile (NASDAQ:ICLR)

About Icon Plc

Icon Plc logoICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ICLR
  • CUSIP:
Key Metrics:
  • Previous Close: $85.35
  • 50 Day Moving Average: $83.05
  • 200 Day Moving Average: $78.55
  • 52-Week Range: $62.31 - $88.90
  • Trailing P/E Ratio: 18.35
  • Foreward P/E Ratio: 14.97
  • P/E Growth: 1.38
  • Market Cap: $4.76B
  • Outstanding Shares: 55,827,000
  • Beta: 0.63
Profitability:
  • Net Margins: 15.60%
  • Return on Equity: 29.47%
  • Return on Assets: 14.43%
Debt:
  • Debt-to-Equity Ratio: 0.40%
  • Current Ratio: 2.20%
  • Quick Ratio: 2.20%
Additional Links:
Companies Related to Icon Plc:

Analyst Ratings

Consensus Ratings for Icon Plc (NASDAQ:ICLR) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $81.50 (4.51% downside)

Analysts' Ratings History for Icon Plc (NASDAQ:ICLR)
Show:
DateFirmActionRatingPrice TargetDetails
1/24/2017Jefferies Group LLCBoost Price TargetHold$84.00 -> $86.00View Rating Details
12/16/2016Goldman Sachs Group, Inc. (The)UpgradeNeutral -> Buy$86.00 -> $90.00View Rating Details
12/16/2016SunTrust Banks, Inc.DowngradeBuy -> Hold$95.00 -> $80.00View Rating Details
10/20/2016Avondale PartnersUpgradeUnderperform -> Market PerformView Rating Details
10/14/2016Evercore ISIUpgradeHold -> Buy$81.50 -> $89.00View Rating Details
7/27/2016KeyCorpReiterated RatingBuy$85.00View Rating Details
6/27/2016Robert W. BairdReiterated RatingOutperform$83.00View Rating Details
6/20/2016Credit Suisse GroupInitiated CoverageOutperform$80.00View Rating Details
4/24/2015Barclays PLCBoost Price TargetEqual Weight$58.00 -> $70.00View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Icon Plc (NASDAQ:ICLR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2017        
2/16/2017Q416$1.26$1.33$440.78 million$435.00 millionViewListenView Earnings Details
10/20/2016Q316$1.18$1.19$420.14 million$420.20 millionViewListenView Earnings Details
7/26/2016Q216$1.14$1.14$409.97 million$411.00 millionViewListenView Earnings Details
4/26/2016Q116$1.11$1.12$414.35 million$400.50 millionViewListenView Earnings Details
2/23/2016Q415$1.10$1.11$409.42 million$403.00 millionViewListenView Earnings Details
10/27/2015Q315$1.01$1.02$399.02 million$394.70 millionViewListenView Earnings Details
7/28/2015Q215$0.89$0.95$402.15 million$389.00 millionViewListenView Earnings Details
4/28/2015Q115$0.82$0.86$391.11 million$388.00 millionViewN/AView Earnings Details
2/25/2015Q4$0.76$0.87$391.37 million$390.10 millionViewN/AView Earnings Details
10/22/2014Q314$0.70$0.79$391.12 million$388.00 millionViewListenView Earnings Details
7/30/2014Q2$0.58$0.64$376.89 million$376.00 millionViewListenView Earnings Details
4/30/2014Q1$0.50$0.57$352.14 million$350.00 millionViewListenView Earnings Details
2/20/2014Q413$0.45$0.53$339.86 million$345.00 millionViewListenView Earnings Details
10/24/2013Q313$0.41$0.45$332.58 million$339.80 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.38$0.43$321.82 million$334.20 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.34$0.36$300.81 million$317.00 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.33$0.34$291.96 million$300.00 millionViewListenView Earnings Details
11/1/2012Q312$0.27$0.29$282.67 million$286.00 millionViewN/AView Earnings Details
7/24/2012$0.22$0.21ViewN/AView Earnings Details
4/24/2012$0.15$0.15ViewN/AView Earnings Details
2/16/2012$0.08$0.07ViewN/AView Earnings Details
10/27/2011$0.02$0.02ViewN/AView Earnings Details
7/20/2011$0.22$0.21ViewN/AView Earnings Details
4/21/2011$0.21$0.21ViewN/AView Earnings Details
2/24/2011$0.36$0.36ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Icon Plc (NASDAQ:ICLR)
Current Year EPS Consensus Estimate: $5.13 EPS
Next Year EPS Consensus Estimate: $5.70 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$1.04$1.14$1.10
Q2 20165$1.10$1.15$1.13
Q3 20165$1.15$1.20$1.18
Q4 20165$1.23$1.29$1.26
Q1 20175$1.22$1.38$1.29
Q2 20175$1.28$1.38$1.33
Q3 20175$1.16$1.25$1.21
Q4 20175$1.22$1.39$1.30
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Icon Plc (NASDAQ:ICLR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Icon Plc (NASDAQ:ICLR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Icon Plc (NASDAQ:ICLR)
DateHeadline
realistinvestor.com logoICON plc (NASDAQ:ICLR) EPS Projection At $1.5167 (NASDAQ:ICLR)
www.realistinvestor.com - February 23 at 5:50 PM
4-traders.com logoICON : Medical Laboratories Stocks Under Scanner -- Exact Sciences, Agilent Technologies, PerkinElmer, and ICON (NASDAQ:ICLR)
www.4-traders.com - February 23 at 4:02 AM
News IconInvestor Guide: Checking on Indicators for ICON PLC (ICLR) - Baxter Review (NASDAQ:ICLR)
baxternewsreview.com - February 22 at 11:00 PM
News IconAre Analysts Optimistic About Where ICON plc (NASDAQ:ICLR) is Heading? - Winfield Review (NASDAQ:ICLR)
winfieldreview.com - February 22 at 11:00 PM
capitalcube.com logoICON Plc :ICLR-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017 (NASDAQ:ICLR)
www.capitalcube.com - February 22 at 5:59 PM
seekingalpha.com logoIcon: Further Operational Improvements Achieved, Steady Growth Continues (NASDAQ:ICLR)
seekingalpha.com - February 22 at 12:44 PM
capitalcube.com logoICON Plc :ICLR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017 (NASDAQ:ICLR)
www.capitalcube.com - February 22 at 12:44 PM
News IconTrialMax Platform Selected by ICON to Measure ePROs in FDA's Antibacterial Drug Trials (NASDAQ:ICLR)
www.pressreleasepoint.com - February 20 at 10:41 AM
uk.finance.yahoo.com logoICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials (NASDAQ:ICLR)
uk.finance.yahoo.com - February 20 at 10:41 AM
finance.yahoo.com logoEdited Transcript of ICLR earnings conference call or presentation 16-Feb-17 2:00pm GMT (NASDAQ:ICLR)
finance.yahoo.com - February 17 at 5:36 PM
biz.yahoo.com logoFull Year 2016 ICON PLC Earnings Call scheduled for 9:00 am ET today (NASDAQ:ICLR)
biz.yahoo.com - February 16 at 9:42 PM
biz.yahoo.com logoFull Year 2016 ICON PLC Earnings Call scheduled for 9:00 am ET today (NASDAQ:ICLR)
biz.yahoo.com - February 16 at 9:42 PM
streetinsider.com logoICON plc (ICLR) Tops Q4 EPS by 7c; Reaffirms (NASDAQ:ICLR)
www.streetinsider.com - February 16 at 4:42 PM
uk.finance.yahoo.com logoICON Reports Fourth Quarter and Full Year 2016 Results (NASDAQ:ICLR)
us.rd.yahoo.com - February 16 at 4:42 PM
us.rd.yahoo.com logo6:03 am ICON plc beats by $0.07, misses on revs; reaffirms FY17 EPS, revs guidance (NASDAQ:ICLR)
us.rd.yahoo.com - February 16 at 4:42 PM
finance.yahoo.com logoIcon PLC meets 4Q profit forecasts - Yahoo Finance (NASDAQ:ICLR)
finance.yahoo.com - February 16 at 8:17 AM
streetinsider.com logoICON plc (ICLR) Tops Q4 EPS by 7c; Reaffirms - StreetInsider.com (NASDAQ:ICLR)
www.streetinsider.com - February 16 at 8:17 AM
sg.finance.yahoo.com logoIcon PLC meets 4Q profit forecasts (NASDAQ:ICLR)
sg.finance.yahoo.com - February 16 at 8:17 AM
biz.yahoo.com logoFull Year 2016 ICON PLC Earnings Release - Time Not Supplied (NASDAQ:ICLR)
biz.yahoo.com - February 16 at 8:17 AM
nasdaq.com logoFirst Week of February 17th Options Trading For Icon (ICLR) - Nasdaq (NASDAQ:ICLR)
www.nasdaq.com - February 15 at 8:55 PM
News IconSADIF Analytics releases new summary due diligence report for ICON PLC ($ICLR). (NASDAQ:ICLR)
reports.pr-inside.com - February 10 at 6:33 PM
News IconEarnings Parade Rolls On, What Are Analysts Saying About ICON plc (NASDAQ:ICLR)? - Wall Street Beacon (NASDAQ:ICLR)
wsbeacon.com - February 1 at 6:34 PM
News IconEarnings in Full Force, Analysts Take Aim at ICON plc (NASDAQ:ICLR) - Wall Street Beacon (NASDAQ:ICLR)
wsbeacon.com - January 27 at 7:48 PM
News IconStock Perspective: ICON plc (NASDAQ:ICLR) Company Earnings Watch - Aiken Advocate (NASDAQ:ICLR)
aikenadvocate.com - January 26 at 7:30 PM
News IconFiera Capital Corp Increased Its Position in Moodys Corp (MCO) by $5.24 Million (NASDAQ:ICLR)
randolphguide.com - January 24 at 6:34 PM
investornewswire.com logoSentiments And Ratings Alert: ICON plc (NASDAQ:ICLR) - Investor Newswire (NASDAQ:ICLR)
www.investornewswire.com - January 12 at 6:17 PM
nasdaq.com logoICLR Crosses Above Average Analyst Target (NASDAQ:ICLR)
www.nasdaq.com - January 11 at 6:28 PM
News IconICON Release: Pharma Issues Financial Guidance For Full Year 2017 (NASDAQ:ICLR)
www.biospace.com - January 10 at 6:44 PM
capitalcube.com logoICON Plc – Value Analysis (NASDAQ:ICLR) : January 10, 2017 (NASDAQ:ICLR)
www.capitalcube.com - January 10 at 6:44 PM
streetinsider.com logoICON plc (ICLR) Offers FY17 Guidance (NASDAQ:ICLR)
www.streetinsider.com - January 9 at 6:34 PM
capitalcube.com logoICON Plc breached its 50 day moving average in a Bullish Manner : ICLR-US : January 9, 2017 (NASDAQ:ICLR)
us.rd.yahoo.com - January 9 at 6:34 PM
uk.finance.yahoo.com logoICON Issues Financial Guidance for Full Year 2017 (NASDAQ:ICLR)
uk.finance.yahoo.com - January 9 at 6:34 PM
finance.yahoo.com logo4:21 pm ICON plc issues financial guidance for FY17 EPS in-line, FY17 revs below consensus, reaffirms FY16 guidance (NASDAQ:ICLR)
finance.yahoo.com - January 9 at 6:34 PM
streetinsider.com logoJefferies Cuts Price Target on ICON plc (ICLR) to $84; Reiterates Hold - StreetInsider.com (NASDAQ:ICLR)
www.streetinsider.com - January 6 at 6:29 PM
realistinvestor.com logoICON plc (NASDAQ:ICLR) Is Expected To Post EPS Of $1.57 (NASDAQ:ICLR)
www.realistinvestor.com - January 5 at 7:03 PM
News IconICON plc (ICLR) Shares Establish New 52-Week High ,Trading ... - BNB Daily (blog) (NASDAQ:ICLR)
www.baseball-news-blog.com - January 2 at 7:19 AM
investornewswire.com logoICON plc (NASDAQ:ICLR) Records An Impact Score Of 21 - Investor Newswire (NASDAQ:ICLR)
www.investornewswire.com - December 29 at 5:53 PM
live-pr.com logo"ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review" Published (NASDAQ:ICLR)
www.live-pr.com - December 19 at 11:40 AM
News IconICON PLC (ICLR) is Upgraded by Goldman to Buy (NASDAQ:ICLR)
larampadinapoli.com - December 19 at 11:40 AM
News IconThe Jefferies Group Reiterates "Hold" Rating for Icon PLC (ICLR) (NASDAQ:ICLR)
www.xboxonezone.com - December 18 at 5:55 PM
News IconIcon PLC (ICLR) Lowered to "Hold" at SunTrust Banks Inc (NASDAQ:ICLR)
www.perspectivabetica.com - December 18 at 5:55 PM
stocksdaily.net logoFY2016 EPS Projection For ICON plc (NASDAQ:ICLR) Set At $5.18 - Stocks Daily (NASDAQ:ICLR)
www.stocksdaily.net - December 17 at 4:29 AM
streetinsider.com logoUPDATE: Goldman Sachs Upgrades ICON plc (ICLR) to Buy - StreetInsider.com (NASDAQ:ICLR)
www.streetinsider.com - December 17 at 4:29 AM
marketexclusive.com logoAnalyst Upgrades – Icon PLC (NASDAQ:ICLR) Stock Gets Upgraded By Goldman Sachs Group Inc. from Neutral to Buy (NASDAQ:ICLR)
marketexclusive.com - December 16 at 6:26 PM
News IconRating Watching: Is ICON plc (ICLR) a Buy? How Analyst Rate it? Why Goldman Sachs Upgraded The Stock (NASDAQ:ICLR)
www.whatsonthorold.com - December 16 at 6:26 PM
us.rd.yahoo.com logoICON plc upgraded by Goldman (NASDAQ:ICLR)
us.rd.yahoo.com - December 16 at 6:26 PM
stocksdaily.net logoStock Price Target Of ICON plc (NASDAQ:ICLR) At $82.812 (NASDAQ:ICLR)
www.stocksdaily.net - December 2 at 5:40 PM
News IconEarnings According to Analysts for ICON plc (NASDAQ:ICLR)? - CSZ News (NASDAQ:ICLR)
cincysportszone.com - November 25 at 10:47 AM
News IconICON Plc ICLR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ICLR)
www.bioportfolio.com - November 20 at 5:23 PM
News IconICON Plc ICLR Financial and Strategic SWOT Analysis Review Prices from USD $300 (NASDAQ:ICLR)
www.bioportfolio.com - November 20 at 9:43 AM

Social

What is Icon Plc's stock symbol?

Icon Plc trades on the NASDAQ under the ticker symbol "ICLR."

Where is Icon Plc's stock going? Where will Icon Plc's stock price be in 2017?

8 equities research analysts have issued 12-month target prices for Icon Plc's stock. Their forecasts range from $59.00 to $90.00. On average, they anticipate Icon Plc's stock price to reach $81.50 in the next twelve months.

When will Icon Plc announce their earnings?

Icon Plc is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.

What are analysts saying about Icon Plc stock?

Here are some recent quotes from research analysts about Icon Plc stock:

  • According to Zacks Investment Research, "ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. " (1/17/2017)

  • Jefferies Group LLC analysts commented, "Focus on operational improvement and tech/analytics enablement is driving new business wins and development of a growing tranche of mid-tier clients. Management is confident in its guidance outlook, though client mix is somewhat less clear. Management is eyeing M&A for some capital deployment, while also expecting to re-authorize share repurchase at its 2016 AGM. Key Topics: 1) win rate improving in key therapeutic areas, driven by differentiated tech, 2) half dozen sizable strategic partnerships, 3) PFE revenue continuing to fade, 4) $400M share repurchase, 5) close to a couple of deals." Tech Suite Driving Differentiation. Firecrest, ADDPLAN, and ICONIK are ICON’s tech platforms aimed at bottlenecks and lower hanging fruit in trial efficiency. Issues of the 2000s like faster database lock at the end of a trial largely have been fixed by use of EDC systems during trials. The refractory issues in trials today are patient recruitment, site education/training/adherence to protocol, and the labor intensive nature of monitoring (think auditing") clinical trial data. ICON owns the industry standard adaptive trial software. Firecrest augments and replaces costly in person meetings, travel, and investigator errors. ICONIK essentially serves as air traffic control on trials, enabling assessment of potentially risky data patterns at the patient, site, and trial level. ICON highlighted that increasing win rates specifically in CNS from a disease-specific analytical package. It is building a second one in oncology." (5/11/2016)

Who owns Icon Plc stock?

Icon Plc's stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (2.72%), William Blair Investment Management LLC (1.80%), Fiera Capital Corp (1.30%), Brown Capital Management LLC (1.05%), Alyeska Investment Group L.P. (0.70%) and Marshall Wace LLP (0.70%).

Who sold Icon Plc stock? Who is selling Icon Plc stock?

Icon Plc's stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Fiera Capital Corp, Castleark Management LLC, Loomis Sayles & Co. L P, Ranger Investment Management L.P., Clark Capital Management Group Inc., Two Sigma Investments LP and Foresters Investment Management Company Inc..

Who bought Icon Plc stock? Who is buying Icon Plc stock?

Icon Plc's stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Russell Investments Group Ltd., Thompson Siegel & Walmsley LLC, Renaissance Technologies LLC, Capstone Investment Advisors LLC, Brown Capital Management LLC and Alyeska Investment Group L.P..

How do I buy Icon Plc stock?

Shares of Icon Plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Icon Plc stock cost?

One share of Icon Plc stock can currently be purchased for approximately $85.35.

Icon Plc (NASDAQ:ICLR) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Icon Plc (NASDAQ:ICLR)

Earnings History Chart

Earnings by Quarter for Icon Plc (NASDAQ:ICLR)

Dividend History Chart

Dividend Payments by Quarter for Icon Plc (NASDAQ:ICLR)

Last Updated on 2/24/2017 by MarketBeat.com Staff